No Data
US Stock MarketDetailed Quotes
ALT Altimmune
Watchlist
6.480
-0.100-1.52% Close 12/08 16:00 ET
6.630+0.150+2.31%
Pre 05:30 ET
7.410High6.370Low28.14MVolume
6.510Open6.580Pre Close193.91MTurnover55.69%Turnover RatioLossP/E (TTM)348.16MMarket Cap17.17052wk HighLossP/E (Static)53.73MShares2.09052wk Low2.32P/B327.48MFloat Cap978.000Historical High--Dividend TTM50.54MShs Float-1731.000Historical Low--Div YieldTTM15.81%Amplitude6.890Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Altimmune Company
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Single Segment-68K100.00%
News
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
Congressman Bernie Sanders (I-Vt.) has been known to tussle with public companies over their high prices or anticompetitive behavior, including pharmaceutical companies and their high costs.In his new
Catalyst Watch: Intel's AI Event, Oracle Earnings and CAVA IPO Lockup Expiration
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.Investors are con
Comments
$Altimmune (ALT.US)$ still here looking forward 🙌 to 9+thank Mr wolf 
1
$Altimmune(ALT.US$ short attack. stay strong and in it
1
3
4
$Altimmune(ALT.US$ I'm in good news
2
$Altimmune(ALT.US$ NO SHORT NEVER BUY 🚭🔥👹 DELETE 👊
2
1
$Altimmune(ALT.US$ gone case no push
1
$Altimmune(ALT.US$ come on Bizotch
2
$Altimmune(ALT.US$ probably 8 by next year
2
1
$Altimmune(ALT.US$ 2.4M shares LTB at FINTEL as of 25 minutes ago! Lets see how many when it updates in about 5 minutes 
4
News
$Altimmune(ALT.US$ Altimmune Reports Topline Results From MOMENTUM 48-Week Phase 2 Obesity Trial Of Pemvidutide; Says Achieved Mean Weight Loss Of 15.6% On 2.4 Mg Dose Of Pemvidutide At Week 48
Benzinga· 1 min ago
Benzinga· 1 min ago
1
2
Watching
$Altimmune(ALT.US$ This has multiple studies in phase 2 and data from one of them should be coming very soon? And data from another should be out, hopefully early first Q 24? All the data for both trials so far is very encouraging for the release of good data.
Earnings win
$Altimmune(ALT.US$ Altimmune Q3 EPS $(0.39) Vs $(0.48) Last Year, Sales $362.00K Up From $2.00K YoY
Moomoo 24/7· 1 min ago
Moomoo 24/7· 1 min ago
1
$Altimmune(ALT.US$
why drop??
why drop??
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Snow Wolf : Shorted! We were close! This one likes to spike $1-$1.50 and drop!